In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria.
about
In vivo activities of newer rifamycin analogs against Mycobacterium avium infectionComparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complexIn vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosisPharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: a phase I study.Preparation and characterization of beta-glucan particles containing a payload of nanoembedded rifabutin for enhanced targeted delivery to macrophages.Early bactericidal activity of rifabutin versus that of placebo in treatment of disseminated Mycobacterium avium complex bacteremia in AIDS patients.Mutation analysis of mycobacterial rpoB genes and rifampin resistance using recombinant Mycobacterium smegmatis.Therapy of multidrug-resistant tuberculosis: lessons from studies with mice.Bacterial challenges and evolving antibacterial drug strategy.Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.Pharmacokinetics of rifapentine in patients with varying degrees of hepatic dysfunction.New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.Controversies in the management of Mycobacterium avium complex infection in AIDS patients.Infection caused by Mycobacterium tuberculosis.Whole genome sequence of the rifamycin B-producing strain Amycolatopsis mediterranei S699.A Note on Derivatives of Isoniazid, Rifampicin, and Pyrazinamide Showing Activity Against Resistant Mycobacterium tuberculosis.Antimicrobial agent resistance in mycobacteria: molecular genetic insights.Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.Incidence of cross resistance between rifampicin and rifabutin in Mycobacterium tuberculosis strains in Izmir, Turkey.
P2860
Q28322002-9EC45C56-B074-4047-8C66-FA329C672C06Q28369712-356B6545-A52C-4566-BBFF-E94FC31AB109Q28379172-4FC57320-C7FF-4532-A952-E9BE2F567C70Q33178187-CCB775EB-3B27-4D2F-8357-E01C028FFB89Q33667215-201C320B-D44B-422E-B91D-05270AF83D9DQ35125757-58094C9B-4A80-47CD-80A9-CB6726CEAE97Q35867423-B3B0C845-E665-4D31-AF54-7C8E31D1D435Q35899883-BE768061-E9D2-470F-9008-5F5613A40D24Q35990358-D0CB495B-875D-487E-BB3D-0DFC5807F514Q36169719-9F901B6A-FAE3-4264-8DF9-E8265936CB76Q36897388-C60B617B-2CE7-45A0-9B72-9545AF626048Q37346929-B58B9AEE-7F91-4472-BBB5-ECEABBC47ADFQ38566706-55010A04-6781-4BF2-A585-702F3C1C31B7Q38569137-A0B2C01F-F541-4C03-9310-531834188339Q38631112-0902ADD6-4B8E-4617-A995-18131F7EBC92Q38650356-63841440-CCE8-4608-B16E-8B3F77911370Q39820619-21010AFC-2FCD-43CE-A25B-C4E6B5AC9EC5Q40095703-BDD8F66F-F7B1-46B4-90D8-3143C1022E8CQ42286897-1F12B1DE-F9DB-4442-8956-383BB3FBD158Q46707118-DE5ABEF4-0420-4699-8CB1-6E3EBC36BE08
P2860
In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
In vitro activity of new rifam ...... and MAIS-complex mycobacteria.
@en
In vitro activity of new rifam ...... and MAIS-complex mycobacteria.
@nl
type
label
In vitro activity of new rifam ...... and MAIS-complex mycobacteria.
@en
In vitro activity of new rifam ...... and MAIS-complex mycobacteria.
@nl
prefLabel
In vitro activity of new rifam ...... and MAIS-complex mycobacteria.
@en
In vitro activity of new rifam ...... and MAIS-complex mycobacteria.
@nl
P1433
P1476
In vitro activity of new rifam ...... and MAIS-complex mycobacteria.
@en
P2093
Dickinson JM
Mitchison DA
P304
P356
10.1016/0041-3879(87)90053-5
P577
1987-09-01T00:00:00Z